前列腺癌患者内分泌治疗相关不良反应的潜在剖面分析
|
朱涵菁, 殷弘凡, 尤思洁, 杨艳
|
Latent profile analysis of adverse effects associated with endocrine therapy in prostate cancer patients based on the theory of unpleasant symptoms
|
ZHU Hanjing, YIN Hongfan, YOU Sijie, YANG Yan
|
|
表5 潜在类别影响因素的多元Logistic回归
|
Tab 5 Multi-variable logistic regression analysis of potential categorical influencing factors
|
|
Item | Moderate symptom | Severe symptom |
---|
β | SE | Wald | P value | OR (95%CI) | β | SE | Wald | P value | OR (95%CI) |
---|
Constant | -3.597 | 1.248 | 8.302 | 0.004 | - | -2.660 | 1.341 | 3.937 | 0.047 | | Psychosocial adjustment score | 0.038 | 0.010 | 13.279 | 0.000 | 1.038 (1.018‒1.060) | 0.026 | 0.012 | 5.065 | 0.024 | 1.027 (1.003‒1.051) | Perceived social support score | -0.002 | 0.008 | 0.047 | 0.827 | 0.998 (0.983‒1.014) | -0.008 | 0.009 | 0.773 | 0.379 | 0.992 (0.975‒1.010) | Uncertainty in illncss score | 0.009 | 0.008 | 1.400 | 0.237 | 1.009 (0.994‒1.024) | 0.021 | 0.008 | 6.532 | 0.011 | 1.021 (1.005‒1.038) | M Stage | | | | | | | | | | | M0 | -0.588 | 0.425 | 1.912 | 0.167 | 0.555 (0.241‒1.278) | -1.037 | 0.489 | 4.499 | 0.034 | 0.354 (0.136‒0.924) | M1 | 0 | - | - | - | - | 0 | - | - | - | - | PSA value | | | | | | | | | | | ≤0.01 ng·mL-1 | -0.062 | 0.520 | 0.014 | 0.905 | 0.940 (0.339‒2.605) | -0.770 | 0.528 | 2.128 | 0.145 | 0.463 (0.164‒1.303) | >0.01 ng·mL-1 and ≤0.2 ng·mL-1 | -0.126 | 0.525 | 0.057 | 0.811 | 0.882 (0.315‒2.467) | -1.953 | 0.622 | 9.859 | 0.002 | 0.142 (0.042‒0.480) | >0.2 ng·mL-1 and ≤ 2 ng·mL-1 | -1.238 | 0.611 | 4.110 | 0.043 | 0.290 (0.088‒0.960) | -1.292 | 0.613 | 4.442 | 0.035 | 0.275 (0.083‒0.914) | >2 ng·mL-1 | 0 | - | - | - | - | 0 | - | - | - | - | Gene detection | | | | | | | | | | | Not done | -1.090 | 0.490 | 4.945 | 0.026 | 0.336 (0.129‒0.879) | -0.569 | 0.575 | 0.980 | 0.322 | 0.566 (0.183‒1.746) | Not mutated | -0.555 | 0.407 | 1.859 | 0.173 | 0.574 (0.259‒1.275) | -0.323 | 0.470 | 0.473 | 0.492 | 0.724 (0.288‒1.819) | Mutated | 0 | - | - | - | - | 0 | - | - | - | - |
|
|
|